15 October 2021>: Clinical Research
The Serum Metabolomics Study of Liver Failure and Artificial Liver Therapy Intervention
Shipeng Huang 1ABC , Dali Hu 2BCD , Songsong Yuan 2BCD , Ying He 2BCD , Chengmu Li 2BCD , Ying Zhu 2BCD , Xiaoping Wu 2AEF*DOI: 10.12659/MSM.930638
Med Sci Monit 2021; 27:e930638
Figure 3 Importance of variables in each group. (A) The main different substances in the liver failure group and the healthy group; (B) the main different substances between the chronic hepatitis group and the healthy group; (C) the main different substances before and after artificial liver treatment.